Testicular Tissue Viability After Cryopreservation

Fertility Clinical Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01262495
• Other study ID #: kabiri HMO-CTIL
• Status: Not yet recruiting
• Phase: N/A
• First received: December 16, 2010
• Last updated: December 16, 2010
• Start date: January 2011
• Est. completion date: December 2011

Study information

• Verified date: December 2010
• Source: Hadassah Medical Organization
• Contact: Doron Kabiri, MD
• Phone: 972-508946898
• Email: doronlilach[@]gmail.com
• Is FDA regulated: No
• Health authority: Israel: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

we will use testicular tissue from patient who underwent orchidectomy due to medical reasons and test the viability of the tissue after cryopreservation and de-freezing.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 5
• Est. completion date: December 2011
• Est. primary completion date: December 2011
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 15 Years to 75 Years

Eligibility

Inclusion Criteria: male patient undergo orchidectomy -

Exclusion Criteria: non viable testicular tissue

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Fertility

Intervention

Other:
• cryopreservation
cryopreservation of testicular tissue

Locations

Country	Name	City	State
Israel	Hadassah Medical Organization	Jerusalem

Sponsors (1)

Lead Sponsor	Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	viable tissue after cryopreservation		1/1/2011 - 30/12/2012	Yes